Cargando…
Cold Atmospheric Plasma Modification of Amyloid β
Cold atmospheric plasma (CAP) has attracted much attention in the fields of biotechnology and medicine owing to its potential utility in clinical applications. Recently accumulating evidence has demonstrated that CAP influences protein structures. However, there remain open questions regarding the m...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003251/ https://www.ncbi.nlm.nih.gov/pubmed/33803786 http://dx.doi.org/10.3390/ijms22063116 |
_version_ | 1783671645759602688 |
---|---|
author | Yagi-Utsumi, Maho Tanaka, Tomohiro Otsubo, Yoko Yamashita, Akira Yoshimura, Shinji Nishida, Motohiro Kato, Koichi |
author_facet | Yagi-Utsumi, Maho Tanaka, Tomohiro Otsubo, Yoko Yamashita, Akira Yoshimura, Shinji Nishida, Motohiro Kato, Koichi |
author_sort | Yagi-Utsumi, Maho |
collection | PubMed |
description | Cold atmospheric plasma (CAP) has attracted much attention in the fields of biotechnology and medicine owing to its potential utility in clinical applications. Recently accumulating evidence has demonstrated that CAP influences protein structures. However, there remain open questions regarding the molecular mechanisms behind the CAP-induced structural perturbations of biomacromolecules. Here, we investigated the potential effects of CAP irradiation of amyloid β (Aβ), an amyloidogenic protein associated with Alzheimer’s disease. Using nuclear magnetic resonance spectroscopy, we observed gradual spectral changes in Aβ after a 10 s CAP pretreatment, which also suppressed its fibril formation, as revealed by thioflavin T assay. As per mass spectrometric analyses, these effects were attributed to selective oxidation of the methionine residue (Met) at position 35. Interestingly, this modification occurred when Aβ was dissolved into a pre-irradiated buffer, indicating that some reactive species oxidize the Met residue. Our results strongly suggest that the H(2)O(2) generated in the solution by CAP irradiation is responsible for Met oxidation, which inhibits Aβ amyloid formation. The findings of the present study provide fundamental insights into plasma biology, giving clues for developing novel applications of CAP. |
format | Online Article Text |
id | pubmed-8003251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80032512021-03-28 Cold Atmospheric Plasma Modification of Amyloid β Yagi-Utsumi, Maho Tanaka, Tomohiro Otsubo, Yoko Yamashita, Akira Yoshimura, Shinji Nishida, Motohiro Kato, Koichi Int J Mol Sci Article Cold atmospheric plasma (CAP) has attracted much attention in the fields of biotechnology and medicine owing to its potential utility in clinical applications. Recently accumulating evidence has demonstrated that CAP influences protein structures. However, there remain open questions regarding the molecular mechanisms behind the CAP-induced structural perturbations of biomacromolecules. Here, we investigated the potential effects of CAP irradiation of amyloid β (Aβ), an amyloidogenic protein associated with Alzheimer’s disease. Using nuclear magnetic resonance spectroscopy, we observed gradual spectral changes in Aβ after a 10 s CAP pretreatment, which also suppressed its fibril formation, as revealed by thioflavin T assay. As per mass spectrometric analyses, these effects were attributed to selective oxidation of the methionine residue (Met) at position 35. Interestingly, this modification occurred when Aβ was dissolved into a pre-irradiated buffer, indicating that some reactive species oxidize the Met residue. Our results strongly suggest that the H(2)O(2) generated in the solution by CAP irradiation is responsible for Met oxidation, which inhibits Aβ amyloid formation. The findings of the present study provide fundamental insights into plasma biology, giving clues for developing novel applications of CAP. MDPI 2021-03-18 /pmc/articles/PMC8003251/ /pubmed/33803786 http://dx.doi.org/10.3390/ijms22063116 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yagi-Utsumi, Maho Tanaka, Tomohiro Otsubo, Yoko Yamashita, Akira Yoshimura, Shinji Nishida, Motohiro Kato, Koichi Cold Atmospheric Plasma Modification of Amyloid β |
title | Cold Atmospheric Plasma Modification of Amyloid β |
title_full | Cold Atmospheric Plasma Modification of Amyloid β |
title_fullStr | Cold Atmospheric Plasma Modification of Amyloid β |
title_full_unstemmed | Cold Atmospheric Plasma Modification of Amyloid β |
title_short | Cold Atmospheric Plasma Modification of Amyloid β |
title_sort | cold atmospheric plasma modification of amyloid β |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003251/ https://www.ncbi.nlm.nih.gov/pubmed/33803786 http://dx.doi.org/10.3390/ijms22063116 |
work_keys_str_mv | AT yagiutsumimaho coldatmosphericplasmamodificationofamyloidb AT tanakatomohiro coldatmosphericplasmamodificationofamyloidb AT otsuboyoko coldatmosphericplasmamodificationofamyloidb AT yamashitaakira coldatmosphericplasmamodificationofamyloidb AT yoshimurashinji coldatmosphericplasmamodificationofamyloidb AT nishidamotohiro coldatmosphericplasmamodificationofamyloidb AT katokoichi coldatmosphericplasmamodificationofamyloidb |